Literature DB >> 21486057

Cells as factories for humanized encapsulation.

Zhengwei Mao1, Regis Cartier, Anja Hohl, Maura Farinacci, Anca Dorhoi, Tich-Lam Nguyen, Paul Mulvaney, John Ralston, Stefan H E Kaufmann, Helmuth Möhwald, Dayang Wang.   

Abstract

Biocompatibility is of paramount importance for drug delivery, tumor labeling, and in vivo application of nanoscale bioprobes. Until now, biocompatible surface processing has typically relied on PEGylation and other surface coatings, which, however, cannot minimize clearance by macrophages or the renal system but may also increase the risk of chemical side effects. Cell membranes provide a generic and far more natural approach to the challenges of encapsulation and delivery in vivo. Here we harness for the first time living cells as "factories" to manufacture cell membrane capsules for encapsulation and delivery of drugs, nanoparticles, and other biolabels. Furthermore, we demonstrate that the built-in protein channels of the new capsules can be utilized for controlled release of encapsulated reagents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21486057     DOI: 10.1021/nl200801n

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  11 in total

1.  Cell-free microfluidic determination of P-glycoprotein interactions with substrates and inhibitors.

Authors:  Klaus Eyer; Michael Herger; Stefanie D Krämer; Petra S Dittrich
Journal:  Pharm Res       Date:  2014-06-14       Impact factor: 4.200

2.  Engineering of erythrocyte-based drug carriers: control of protein release and bioactivity.

Authors:  Rongcong Luo; Shaillender Mutukumaraswamy; Subbu S Venkatraman; Björn Neu
Journal:  J Mater Sci Mater Med       Date:  2011-11-18       Impact factor: 3.896

Review 3.  Nanoyeast and Other Cell Envelope Compositions for Protein Studies and Biosensor Applications.

Authors:  Yadveer S Grewal; Muhammad J A Shiddiky; Stephen M Mahler; Gerard A Cangelosi; Matt Trau
Journal:  ACS Appl Mater Interfaces       Date:  2016-11-04       Impact factor: 9.229

4.  Evaluation of Cytochalasin B-Induced Membrane Vesicles Fusion Specificity with Target Cells.

Authors:  Marina Gomzikova; Sevindzh Kletukhina; Sirina Kurbangaleeva; Albert Rizvanov
Journal:  Biomed Res Int       Date:  2018-04-08       Impact factor: 3.411

5.  Immunosuppressive properties of cytochalasin B-induced membrane vesicles of mesenchymal stem cells: comparing with extracellular vesicles derived from mesenchymal stem cells.

Authors:  M O Gomzikova; A M Aimaletdinov; O V Bondar; I G Starostina; N V Gorshkova; O A Neustroeva; S K Kletukhina; S V Kurbangaleeva; V V Vorobev; E E Garanina; J L Persson; J Jeyapalan; N P Mongan; S F Khaiboullina; A A Rizvanov
Journal:  Sci Rep       Date:  2020-07-01       Impact factor: 4.379

Review 6.  Therapeutic Application of Mesenchymal Stem Cells Derived Extracellular Vesicles for Immunomodulation.

Authors:  Marina O Gomzikova; Victoria James; Albert A Rizvanov
Journal:  Front Immunol       Date:  2019-11-15       Impact factor: 7.561

7.  Multi-modal liquid biopsy platform for cancer screening: screening both cancer-associated rare cells and cancer cell-derived vesicles on the fabric filters for a reliable liquid biopsy analysis.

Authors:  Jiyoon Bu; Jae-Eul Shim; Tae Hee Lee; Young-Ho Cho
Journal:  Nano Converg       Date:  2019-11-15

8.  Cytochalasin-B-Inducible Nanovesicle Mimics of Natural Extracellular Vesicles That Are Capable of Nucleic Acid Transfer.

Authors:  Anastasiya Oshchepkova; Alexandra Neumestova; Vera Matveeva; Lyudmila Artemyeva; Ksenia Morozova; Elena Kiseleva; Marina Zenkova; Valentin Vlassov
Journal:  Micromachines (Basel)       Date:  2019-11-01       Impact factor: 2.891

9.  Cell Membrane Vesicles with Enriched CXCR4 Display Enhances Their Targeted Delivery as Drug Carriers to Inflammatory Sites.

Authors:  Dandan Wang; Shengjie Jiang; Fengyi Zhang; Siqin Ma; Boon Chin Heng; Yuanyuan Wang; Junxia Zhu; Mingming Xu; Ying He; Yan Wei; Xuehui Zhang; Bin Xia; Xuliang Deng
Journal:  Adv Sci (Weinh)       Date:  2021-10-23       Impact factor: 16.806

10.  Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells.

Authors:  Marina O Gomzikova; Margarita N Zhuravleva; Regina R Miftakhova; Svetlana S Arkhipova; Vladimir G Evtugin; Svetlana F Khaiboullina; Andrey P Kiyasov; Jenny L Persson; Nigel P Mongan; Richard G Pestell; Albert A Rizvanov
Journal:  Oncotarget       Date:  2017-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.